UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond

Journal of the American Heart Association, 2020-10, Vol.9 (19), p.e017787-e017787

2020

Volltextzugriff (PDF)

Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14

Journal of clinical oncology, 2011-10, Vol.29 (29), p.3869-3876

2011

Volltextzugriff (PDF)

Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?

Journal of clinical medicine, 2020-03, Vol.9 (4), p.896

2020

Volltextzugriff (PDF)

Practical Cardio-Oncology

Dent, Susan F

1st edition., 2019

Volltextzugriff (PDF)

Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis

European heart journal, 2022-01, Vol.43 (4), p.300-312

2022

Volltextzugriff (PDF)

Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique

NPJ breast cancer, 2024-01, Vol.10 (1), p.12-12, Article 12

2024

Volltextzugriff (PDF)

Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer

Current oncology reports, 2021-11, Vol.23 (11), p.128, Article 128

2021

Volltextzugriff (PDF)

Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium

Journal of Cancer, 2019-01, Vol.10 (15), p.3344-3351

2019

Volltextzugriff (PDF)

Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2021-07, Vol.144 (3), p.e41-e55

2021

Volltextzugriff (PDF)

Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society

JACC CardioOncology, 2021-09, Vol.3 (3), p.360-380

2021

Volltextzugriff (PDF)

Cardioprotective Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Cancer Treated With Anthracyclines: An Observational Study

The American journal of cardiology, 2024-07, Vol.222, p.175-182

2024

Volltextzugriff (PDF)

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

Breast cancer research and treatment, 2011-04, Vol.126 (2), p.295-310

2011

Volltextzugriff (PDF)

The underutilization of preventive cardiovascular measures in patients with cancer: an analysis of the Behavioural Risk Factor Surveillance System, 2011-22

European journal of preventive cardiology, 2023-09, Vol.30 (13), p.1325-1332

2023

Volltextzugriff (PDF)

Cardiometabolic Consequences of Targeted Anticancer Therapies

Journal of cardiovascular pharmacology, 2022-10, Vol.80 (4), p.515-521

2022

Volltextzugriff (PDF)

Coverage for evidence-based cancer survivorship care services

Supportive care in cancer, 2024-03, Vol.32 (3), p.165-165, Article 165

2024

Volltextzugriff (PDF)

Cardio-oncology in clinical studies and real life

Seminars in oncology, 2019-12, Vol.46 (6), p.421-425

2019

Volltextzugriff (PDF)

The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415

Supportive care in cancer, 2024-08, Vol.32 (8), p.528, Article 528

2024

Volltextzugriff (PDF)

How to Manage and Monitor Cardiac Dysfunction in Patients With Metastatic HER2-Positive Breast Cancer

JACC CardioOncology, 2022-09, Vol.4 (3), p.404-408

2022

Volltextzugriff (PDF)

Ontario Cancer Research Ethics Board: Lessons Learned From Developing a Multicenter Regional Institutional Review Board

Journal of clinical oncology, 2008-03, Vol.26 (9), p.1479-1482

2008

Volltextzugriff (PDF)

Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial

Journal of evaluation in clinical practice, 2019-04, Vol.25 (2), p.196-204

2019

Volltextzugriff (PDF)

Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity

American Society of Clinical Oncology educational book, 2020-03, Vol.40 (40), p.1-515

2020

Volltextzugriff (PDF)

An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy

Journal of Oncology, 2015-01, Vol.2015 (2015), p.174-177

2015

Volltextzugriff (PDF)

Competing risks of death in younger and older postmenopausal breast cancer patients

World journal of clinical oncology, 2014-12, Vol.5 (5), p.1088-1096

2014

Volltextzugriff (PDF)

phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer

Cancer chemotherapy and pharmacology, 2010-02, Vol.65 (3), p.557-561

2010

Volltextzugriff (PDF)

iPractical Cardio-Oncology

Dent, Susan F.

1, 2020

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(102)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond

Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14

Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?

Practical Cardio-Oncology

Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis

Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique

Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer

Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium

Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association

Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society

Cardioprotective Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Cancer Treated With Anthracyclines: An Observational Study

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

The underutilization of preventive cardiovascular measures in patients with cancer: an analysis of the Behavioural Risk Factor Surveillance System, 2011-22

Cardiometabolic Consequences of Targeted Anticancer Therapies

Coverage for evidence-based cancer survivorship care services

Cardio-oncology in clinical studies and real life

The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415

How to Manage and Monitor Cardiac Dysfunction in Patients With Metastatic HER2-Positive Breast Cancer

Ontario Cancer Research Ethics Board: Lessons Learned From Developing a Multicenter Regional Institutional Review Board

Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial

Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity

An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy

Competing risks of death in younger and older postmenopausal breast cancer patients

phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer

iPractical Cardio-Oncology

Suchergebnisse filtern